The results of a study revealed a role of CFTR in glucose-induced electrical activities and insulin secretion in β-cells (36).  Grishman et al. study proposed a glyburide as one of the potential therapies to decrease the progression of T1D due its ability to decrease IL1β levels (37). Here, IL1B is linked to type 1 diabetes mellitus.